Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.80 USD
-0.01 (-0.28%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $1.80 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 21 - 40 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Inevitable Combination with HEXO Doesn''t Change Tilray''s Course
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: Toronto Securities Exchange an Open Pathway for MSO Lisitngs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: 280E Removal Would Bring More Than Just Financial Leverage
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
2Q23 Miss, Ops Efficiencies & Cost Savings Focus on FCF Positive
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly Rehash: Federal Legalization Globally Progressing Faster Than U.S.
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: SAFE Banking + Unlocks Coming
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
1Q23 In-Line Flat Growth, Margin Expansion in ''23, Neutral and PT to $3
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: Biden Announces Pardons, Urged CSA Review
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S